Metoprolol Improves Endothelial Function in Patients with Cardiac Syndrome X

Endothelial dysfunction which is manifested by the loss of nitric oxide bioavailability, is an increasingly recognized cause of cardiac syndrome X (CSX) and beta blockers are used for the treatment of this syndrome. Thus, the aim of this study was to investigate effects of metoprolol, as a beta bloc...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Iran J Pharm Res
Päätekijät: Majidinia, Maryam, Rasmi, Yousef, Khadem Ansari, Mohammad Hassan, Seyed-Mohammadzad, MirHossein, Saboory, Ehsan, Shirpoor, Alireza
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Shaheed Beheshti University of Medical Sciences 2016
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5149044/
https://ncbi.nlm.nih.gov/pubmed/27980592
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia